Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses CECO Q1 2026 Earnings EPS Smashes Estimates by 140 Yet Stock Drops on Revenue Concerns KEP Q4 2025 Earnings EPS Miss Weighs on Shares Amid Cost Pressures BBAI Q1 2026 Earnings EPS Misses Estimates as Company Navigates AI Market Headwinds COST Q1 2026 Earnings EPS Misses Estimates Stock Declines CICC Q1 2026 Earnings EPS Falls Short of Estimates Stock Slides 06